Biocompatible Sterile Packaging Foil for IV Solution Infusion

Name: Biocompatible Sterile Packaging Foil for IV Solution Infusion
Brand: Jiangsu Best New Medical Material Co., Ltd.
SKU: 2310971605

Jiangsu, ChinaJiangsu Best New Medical Material Co., Ltd.

US$0.85-1.00

260 Square Meters

Sample price:US$5.00/square meter.Request sample

Product profile

Customization

Available

Industrial Use

Pharmaceutical

Transparency

Transparent

Model NO.

BS-F001

Layered

Heat Seal

Hardness

Soft

Basic Level

BOPP

Heat Seal

CPP

Functional Layer

EVOH

Packaging

Bag

Color

Transparent

Wildth

Customized

Thickness

200~220

Struction

Three Layers

Transport Package

Carton

Trademark

JSBEST

Origin

China

HS Code

3920200000

Production Capacity

5000000

Company profile

Importers and ExportersQuality AssuranceR&D CapabilitiesManagement Certification

Jiangsu Best New Medical Material Co., Ltd.

Jiangsu, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs CertifiedExport Year: 1 Year CertifiedNearest Port: Shanghai PortAverage Response Time: ≤3.34h

AI-Powered supplier vetting

SummaryJiangsu Best New Medical Materials Co., Ltd. is a medical-materials manufacturer and a holding subsidiary of Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Its stated scope covers membrane materials, medical packaging materials, plastics, and related technology development. The supplier reports OEM service for well-known brands, one national science and technology progress award, ISO9001:2015, ISO45001:2018, and ISO14001 certifications, documented quality and complaint procedures, contracted manufacturing capacity, inventory capability, and production equipment for films, rubber products, packaging, and purified water processing. It supports sample- and design-based customization and has self-operated import/export rights. Limitations include no SDK, overseas warehouse, overseas showroom, or overseas agent/branch, and no stated Fortune 500 customer collaboration. Financial information is represented only by year labels, so financial strength cannot be assessed from the provided evidence.

Supplier typeThe supplier is presented as a manufacturer of new membrane materials, medical packaging materials, plastic products, rubber products, films, infusion components, and related products. Its listed production lines and self-operated import/export rights further support classification as a manufacturing supplier with export capability.

CertificationsThe supplier reports ISO9001:2015, ISO45001:2018, and ISO14001 management-system certificates, as well as other unspecified certifications. The evidence explicitly confirms multiple recognized management-system certifications, although the product-compliance certification is only identified as “Others.”

After-Sales capabilityThe supplier has documented procedures and records for corrective and preventive actions and customer complaints, plus inventory capability and stated lead times of within 15 working days in both peak and off-season. However, it has no overseas warehouse, showroom, agent, or branch, limiting documented overseas service infrastructure.

R&D capabilityThe business scope includes new material technology research and development, and the supplier reports one national science and technology progress award. However, it does not have an available SDK, so the evidence supports material-related R&D capability but not software-development or SDK capability.

Production capacityThe supplier reports valid manufacturing-capacity contracts with each related subcontractor, inventory capability, documented inspection and quality-assurance procedures, and equipment including extrusion, vulcanizing, washing, packing, purified-water, and biofilm production lines. These records provide explicit evidence of established production and quality-control capacity.

Customization capabilityThe supplier explicitly supports customization from samples and from customer designs. This directly demonstrates both sample-based and design-based customization capability.

Client casesThe supplier reports OEM service for well-known brands and participation in the API China 2023 offline trade show. It also explicitly reports no collaboration with Fortune 500 companies; no named customer cases or detailed project outcomes are provided.